Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs Sertraline for Anxiety in Epilepsy
NCT01309074Phase 4Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of pregabalin in anxiety disorder (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Improvement of anxiety symptoms measured with the changes of the total scores of GAD-7 & HAM-A at 27 weeks. Planned start Nov 2009; status: withdrawn.
02
Drugs
pregabalin
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT01309074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309074.